Johnson, Brett E <br/><br/>
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.  [electronic resource] 

 -  Science (New York, N.Y.)  Jan 2014 
 - 189-193 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-9203 
<br/><br/><label>Standard No.: </label>10.1126/science.1239947  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Brain--drug effects<br/>Brain Neoplasms--drug therapy<br/>DNA Helicases--genetics<br/>DNA Mutational Analysis<br/>Dacarbazine--adverse effects<br/>Glioma--drug therapy<br/>Humans<br/>Mutagenesis--drug effects<br/>Neoplasm Grading<br/>Neoplasm Recurrence, Local--chemically induced<br/>Nuclear Proteins--genetics<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>TOR Serine-Threonine Kinases--genetics<br/>Temozolomide<br/>Transcription Factors--genetics<br/>Tumor Suppressor Protein p53--genetics<br/>X-linked Nuclear Protein